Abstract
The cellular immune response of 8 patients from the Brazilian Amazon region with chromoblastomycosis was analyzed. Primary immunological responses of patients were tested by contact sensitization to 2,4-dinitro-chlorobenzene (DNCB), or rejection of first set skin allografts. 2 of 8 patients were reactive to DNCB after sensitization, and skin allograft rejection occured in an average of 14 days. Capacity of patients to mount recall immunological responses was measured by skin testing with two fungal antigens and three bacterial antigens. Delayed skin reaction to trichophytin and Candida antigens was negative in the majority of the patients. However, reactivity to mycobacterial (tuberculin), and bacterial (staphylococcal, streptococcal) antigen was high, or only slightly diminished respectively. The data suggest that patients with chromoblastomycosis have suppressed nonspecific, cell mediated immunity for some antigens (skin allografts, DNCB, fungal antigens), while reactivity to bacterial and mycobacterial antigens is not impaired.
Similar content being viewed by others
References
Pedroso A, Gomes JM. Sobre quatro casos de dermatite verrucosa produzida pelo Phialophora verrucosa. An Paul Med Cir 1920; 11: 53–55.
Rudolph M. Über die brasilianische ‘Figueira’. Arch Schiffs Tropen Hyg 1914; 18: 498.
Carrion AL. Chromoblastomycosis. Ann NY Acad Sci 1950; 50: 1255–1282.
McGinnis MR. Chromoblastomycosis and phaeohypomycosis: new concepts, diagnosis and mycology. J Am Acad Dermatol 1991; 8: 1–16.
Vollum DI. Chromomycosis: A review. Br J Dermatol 1977; 96: 454–458.
Lavalle P. Chromomykose. Handbuch der Haut- und Geschlechtskrankheiten, J. Jadasohn. Die Pilzkrankheiten der Haut duch Hefen, Schimmel, Aktinomyceten und verwandte Erreger, Marchionini A, Götz H, eds. Berlin: Springer Verlag, 1963; Ergänzungswerk, Vierter Band, Vierter Teil: 367–435.
Conant NF, Smith DT, Baker RD, Callaway JL, Martin DS. Manual of clinical mycology. Philadelphia: W.B. Saunders, 1954: 262–283.
Catalona WJ, Taylor PT, Chretien PB. Quantitative dinitrochlorobenzene contact sensitization in a normal population. Clin Exp Immunol 1972; 21: 325–333.
Catalona WJ, Taylor PT, Rabson AS. A method for dinitrochlorobenzene contact sensitization. A clinicopathological study. N Engl J Med 1972; 286: 399–402.
Lima AO, Soares JB, Greco JB. Metodes de laboratorio aplicados a clinica. Rio de Jainero: Editoria Guanabara Koogan, 1969.
Pecher SA, Croce J, Ferri GR. Study of humoral and cellular immunity in lobomycosis. Allergol Immunopathol 1979; 7: 439–444.
Pecher SA, Fuchs J. Cellular immunity in lobomycosis (keloidal blastomycosis). Allergol Immunopathol 1988; 16: 413–415.
Rapaport FT, Thomas L, Converse JM, Lawrence HS. The specificity of skin homograft rejection in man. Ann NY Acad Sci 1960; 87: 217–222.
Dyson JE, Evans EE. Delayed hypersensitivity in experimental fungus infections: The skin reactivity of antigens from the yeast phase of Blastomyces dermatitidis. J Invest Dermatol 1955; 24: 447–454.
Mendes NF, Musati CC, Leao RC, Mendes E, Naspitz CK: Lymphocyte cultures and skin allograft survival in patients with South American Blastomycosis. J Allergy 1971; 47: 17–22.
Musatti CC, Rezkallah MT, Mendes E, Mendes NF. In vivo and in vitro evaluation of cell mediated immunity in patients with paracoccidioidomycosis. Cell Immun 1976; 24: 365–378.
Fernandez Baquero G. La intradermoreacion con antigeno de Hormodendrum pedrosoi. Bol Soc Cubana Derm Sif 1959; 16: 90–94.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fuchs, J., Pecher, S. Partial suppression of cell mediated immunity in chromoblastomycosis. Mycopathologia 119, 73–76 (1992). https://doi.org/10.1007/BF00443936
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00443936